Urology Case Reports (Sep 2020)

Durable biochemical response following adrenal metastasectomy for oligometastatic castrate-resistant prostate cancer

  • Akbar N. Ashrafi,
  • Carlos Fay,
  • Wesley Yip,
  • Daniel M. de Freitas,
  • Jamal Nabhani,
  • Monish Aron

Journal volume & issue
Vol. 32
p. 101229

Abstract

Read online

A 77 year-old man was referred to Urology with an enlarging left adrenal mass after treatment with androgen deprivation therapy for metastatic castrate-resistant prostate cancer. He underwent a robotic-assisted left radical adrenalectomy, with pathology revealing metastatic adenocarcinoma consistent with a primary prostate adenocarcinoma. The patient had a durable oncological response to metastasectomy with no evidence of biochemical or radiological recurrence after 5 years of follow-up. Adrenal metastases from prostate cancer are extremely rare, representing only 1% of metastatic cases. Surgical resection of oligometastatic prostate cancer recurrences may be considered in select patients and may improve progression-free survival.

Keywords